肺癌救星-易瑞沙(吉非替尼)疗效及复查时间(Lung cancer Savior - Iressa (gefitinib) effect and review time).docVIP
- 5
- 0
- 约6.5千字
- 约 5页
- 2018-05-30 发布于河南
- 举报
肺癌救星-易瑞沙(吉非替尼)疗效及复查时间(Lung cancer Savior - Iressa (gefitinib) effect and review time)
肺癌救星-易瑞沙(吉非替尼)疗效及复查时间(Lung cancer Savior - Iressa (gefitinib) effect and review time)
Drug Iressa (Iressa) the emergence of the lung cancer patients suffering from chemotherapy, clinical studies prove the efficacy of Iressa in patients with lung cancer is very significant.
Iressa is developed by an international research team, taking a daily Iressa lung cancer patients, the patients received chemotherapy and prolonging the life time is the same. This is the first oral biological agent in the study of lung cancer, said Dr. Edward Kim of the University of Texas Anderson Cancer Research Center at the University of Texas in the United states. Dr. King, along with his team, tested 1466 lung cancer patients in 24 countries worldwide. These patients after the first stage of chemotherapy, half taking Iressa as second course of treatment, the other half in accordance with traditional therapy received docetaxel (a chemotherapy agent) treatment. Results showed that the average life span of two patients was 8 months at the same time.
Dr Michael Cullen, of the University of Birmingham, said that Yi Ray Chebbis traditional chemotherapy had less side effects, less harm to patients and easier access to drugs. There will be a lot of lung cancer patients in favor of iressa.
Every year, 1 million 200 thousand people die of lung cancer worldwide, and some drugs for lung cancer gradually fail and fail to save their lives. At present, Iressa still needs more testing, because not all are suitable for lung cancer patients taking iressa. The test shows that non-smokers, Asians and female lung cancer patients, more suitable for taking iressa.
Then, Iressa (gefitinib) effect which features?
1., better efficacy
Targeted therapy can significantly alleviate the clinical symptoms of tumor patients and prolong the survival time for patients with advanced non-small cell lung cancer. At the same time, compared with traditional chemotherapy, targeted therapy is better tolerated, safer and more qualit
您可能关注的文档
- 小人物何以带来大感动(Small character Why bring great move).doc
- 古今伤病灾标志(Injury marks of ancient and modern diseases and injuries).doc
- 网站运营之思维模式分老聂析(The thinking mode of website operation of laonie analysis).doc
- 网络团购运营模式初探(Discussion on online group buying operation mode).doc
- 网络安全术语解释(第一版)-创意安天推荐(Explain the terms of network security (First Edition) - creative antiy recommended).doc
- 网站设计65条原则(65 principles of Web Design).doc
- 网络传播权探析(Analysis of network communication right).doc
- 网络幽默搞笑俏皮话(Network humor, funny, witty words).doc
- 网络推荐的创业者阅读书目(Web recommended entrepreneur reading list).doc
- 网络版全国教师资格认定管理信息系统任教学科对照表(Online version of the national teacher qualification accreditation management information system).doc
最近下载
- DB11_T 2478-2025 碘-131核素治疗病房辐射安全与防护要求.pdf VIP
- NB-T-47018.1~47018.5-2017-承压设备用焊接材料订货技术条件+编制说明_.pdf VIP
- DBJ51_T 233-2023 四川省光伏建筑一体化应用技术标准(CTP).pdf VIP
- DB11_T 2492-2025 消防通信指挥系统应用规范 (1).pdf VIP
- 大众电影封面全集1950-1991170p.doc VIP
- DB11_T 136-2025 汽车维护竣工出厂技术条件.pdf VIP
- DB11_T 783-2025 建设用地土壤修复与风险管控效果评估技术规范.pdf VIP
- DB11_T 1312-2025 预制混凝土构件质量控制标准.pdf VIP
- DB11_T 1322.81-2025 安全生产等级评定技术规范 第81部分:歌舞娱乐场所.pdf VIP
- DB11_T 1322.82-2025 安全生产等级评定技术规范 第82部分:营业性演出场所.pdf VIP
原创力文档

文档评论(0)